Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
2.700
-0.050 (-1.82%)
May 19, 2026, 4:00 PM EDT - Market closed
Nasus Pharma Employees
Nasus Pharma had 7 employees as of December 31, 2025. The number of employees increased by 5 or 250.00% compared to the previous year.
Employees
7
Change (1Y)
5
Growth (1Y)
250.00%
Revenue / Employee
n/a
Profits / Employee
-$836,571
Market Cap
31.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | 5 | 250.00% | 7 | 0 |
| Dec 31, 2024 | 2 | - | - | 1 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| GSK plc | 66,841 |
| Bristol-Myers Squibb Company | 32,500 |
| Grifols | 25,247 |
| Organon & Co. | 10,000 |
| Biogen | 7,500 |
| Amarin Corporation | 80 |
NSRX News
- 18 days ago - Nasus Pharma to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Nasus Pharma Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts
- 7 weeks ago - Nasus Pharma price target lowered to $18 from $19 at Citizens - TheFly
- 7 weeks ago - Nasus Pharma Earnings release: Q4 2025 - Filings
- 7 weeks ago - Nasus Pharma Annual report: Q4 2025 - Filings
- 7 weeks ago - Nasus Pharma Earnings release: Q4 2025 - Filings
- 7 weeks ago - Nasus Pharma advances NS002 to pivotal study following Phase 2 results - TheFly
- 7 weeks ago - Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update - GlobeNewsWire